HomeAI · summaries
Storia in 3 fonti
Exclusive: Cambridge's Qureight raises $20M to bring AI to lung and heart clinical trials — TFN
Cambridge startup Qureight has raised a $20 million Series B led by Molten Ventures to expand its AI imaging platform for lung and heart clinical trials.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
techfundingnews.com
Exclusive: Cambridge's Qureight raises $20M to bring AI to lung and heart clinical trials — TFN
Cambridge startup Qureight has raised a $20 million Series B led by Molten Ventures to expand its AI imaging platform for lung and heart clinical trials.
- ·
tech.eu
Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials
Series B funding will accelerate development of new AI disease models for lung and heart conditions, while expanding the company's imaging analytics platform.
